BookBob Yang, Steve Foley, editors.
Summary: This book comprehensively covers the latest consensus in the diagnosis and management of patients with recurrent Urinary Tract Infections (UTIs). It features a broad overview of the basic science and the spread of antibiotic resistance in UTIs. Guidelines are provided on the recommended approaches for using antibiotics including dosage, duration, resistance rates for a range of antibiotics, and available methods for combating antibiotic resistance. Further topics covered include prophylaxis, including conservative lifestyle modifications as well as preventative therapies. Female Urinary Tract Infections in Clinical Practice summarises the basic science, use of antibiotics, and preventative strategies for UTIs and represents a timely and valuable resource for all practising and trainee medical professionals who encounter these patients in their practice. .
Contents:
Intro; Introduction; Contents;
Chapter 1: Pathophysiology of UTIs; 1.1 Six Categories of UTIs; 1.2 How Do UTIs Occur?; 1.3 Natural Defences; 1.4 What Are the Risk Factors and Why?; 1.5 Gender-Related; 1.6 Functional; 1.7 Disease-Related/Iatrogenic; 1.8 Genetic; 1.9 Asymptomatic Bacteriuria; References;
Chapter 2: Presentation and Diagnosis; 2.1 Clinical Symptoms; 2.2 History; 2.3 Examination; 2.4 Urine Analysis; 2.5 Further Investigations; References;
Chapter 3: Role of Imaging in UTIs; 3.1 Introduction; 3.2 Diagnostic Indications; 3.3 Imaging Modalities; 3.4 Uncomplicated UTI 3.5 Complicated UTI3.6 Imaging Findings in Acute UTI; 3.6.1 Cystitis; 3.6.2 Pyelonephritis; 3.6.3 Hydronephrosis and Pyonephrosis; 3.6.4 Pyonephrosis; 3.6.5 Renal Abscess; 3.7 Imaging in Recurrent UTIs; 3.7.1 Chronic Pyelonephritis; 3.7.2 Urinary Tract Tuberculosis; References;
Chapter 4: Antibiotics; 4.1 Trimethoprim; 4.2 Nitrofurantoin; 4.3 Penicillin; 4.4 Fluoroquinolones; 4.5 Aminoglycosides; 4.6 Fosfomycin; 4.7 Cephalosporin; 4.8 Carbapenems; 4.9 Multidrug-Resistance Bacteria; 4.10 Antibiotics Prophylaxis; References;
Chapter 5: Lifestyle Modifications; 5.1 Introduction 5.2 Oral Hydration5.3 Sexual Hygiene; 5.4 Personal Hygiene; 5.5 Voiding; 5.6 Weight Loss; References;
Chapter 6: Cranberry; 6.1 Introduction and Mechanism of Action; 6.2 Clinical Evidence; References;
Chapter 7: d-Mannose; 7.1 Introduction and Mechanism of Action; 7.2 Clinical Evidence; References;
Chapter 8: Methenamine Hippurate (Hiprex); 8.1 Introduction and Mechanism of Action; 8.2 Clinical Evidence; References;
Chapter 9: Oestrogen Replacement Therapy; 9.1 Introduction and Mechanism of Action; 9.2 Clinical Evidence; 9.3 Oral Oestrogen; References;
Chapter 10: Traditional Chinese Medicine 10.1 Introduction and Mechanism of Action10.2 Formulations; 10.3 Clinical Evidence; 10.4 Acupuncture; References;
Chapter 11: Intravesical Therapies; 11.1 Introduction; 11.2 The Procedure Itself; 11.3 Intravesical Antibiotics (IVA); 11.4 Clinical Evidence; 11.5 Non-antibiotic Instillations (GAG Layer Replacement); 11.6 Clinical Evidence; 11.7 Limitation of Intravesical Therapies; References;
Chapter 12: Fractional CO2 Thermo-Ablative Vaginal Laser Therapy; 12.1 Introduction and Mechanism of Action; 12.2 Clinical Evidence; References;
Chapter 13: Immunomodulation Vaccines 13.1 Introduction and Mechanism of Action13.2 Clinical Evidence; 13.2.1 UroVaxom®; 13.2.2 Urovac®; 13.2.3 ExPEC4V; 13.2.4 Uromune®; References;
Chapter 14: Urinary Tract Infections of the Neurogenic Bladder; 14.1 Pathophysiology; 14.1.1 Precipitating Factors; 14.1.1.1 Voiding; 14.1.1.2 Catheters; 14.1.1.3 Stones; 14.1.1.4 Obstruction; 14.1.1.5 Bowel Dysfunction; 14.2 Definition of UTI in NLUT; 14.2.1 Urine Analysis; 14.2.2 Positive Urine Culture; 14.3 Clinical Evaluation of Neurogenic Bladder; 14.3.1 Clinical Examination and Investigations